PLOD1 and Gynecomastia: In our department, treatment with testosterone is typically initiated when LH exceeds +2 SDS or if the patient has symptoms or develops phenotypic traits associated with testosterone deficiency (e.g. gynecomastia, increased fat percentage, and diminished virilization).